Investors Overview
Invest in sustainable success
The Sonova Group is one of the broadest hearing care providers in the world. The company has a strong track record in achieving solid financial results. Serving a growing global market with a comprehensive range of innovative hearing solutions, Sonova is well positioned to achieve sustainable success in the long run. Get the latest news, reports and presentations from the company here.

Investor news
-
Andy Rihs controls 4.83% of Sonova Holding AG
Home » Investors Aug 12, 2014 | 5:30 AM Andy Rihs controls 4.83% of Sonova Holding AG Stäfa (Switzerland), 12 August, 2014– According to the article 20 of the Swiss Stock Exchange Act, Sonova Holding AG announces that Andy Rihs, 8634 Hombrechtikon, now controls 3,245,233 registered shares with a par…
-
BlackRock, Inc. controls less than 3% of Sonova Holding A
Home » Investors Jun 26, 2014 | 5:30 AM BlackRock, Inc. controls less than 3% of Sonova Holding A Staefa (Switzerland), 26 June 2014– According to the article 20 of the Swiss Stock Exchange Act, Sonova Holding AG announces that BlackRock, Inc., 55 East 52nd Street, New York, 10055, U.S.A. (mother…
-
Sonova shareholders approved all motions of the Board of Directors
Stäfa (Switzerland), 17 June 2014 – The shareholders of Sonova Holding AG approved all motions of the Board of Directors at the Annual General Shareholders’ Meeting (AGM) on June 17, 2014, and decided on a dividend of CHF 1.90 per share. 467 shareholders attended the AGM of Sonova Holding AG in…
Presentations & webcasts
-

Full-Year Results 2025/26
-

Sonova Strategy Update
Financial calendar
Latest reports
-

Full-Year Results 2025/26
-

Annual Report 2024/25
Share quote
Key figures
| Sales | CHF 3.6 billion |
| EBITA | CHF 811.2 million* |
| Income after taxes | CHF 546 million |
| R&D spending | CHF 217.7 million* |
| Dividend per share | CHF 4.70 |
| Number of employees | 18,000 |
* normalized
Sonova news alert
Corporate governance reports
Please find the latest Corporate Governance Reports here.

Current outlook
Investor relations
-

Peter Dickson
-

Thomas Bernhardsgrütter
-

Olivier Fergg
-

Nicole Jenni